Status:
TERMINATED
Observational Study Of Donepezil In Routine Clinical Practice
Lead Sponsor:
Pfizer
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
50+ years
Brief Summary
To characterize the comorbidities and medications of patients treated with donepezil in a routine clinical practice and to verify the therapeutic response of these patients.
Detailed Description
This trial was terminated prematurely on December 31, 2007 due to difficulties in enrolling patients in the study. There were no safety or efficacy concerns regarding the study in the decision to term...
Eligibility Criteria
Inclusion
- DSM-IV criteria for the clinical diagnosis of mild to moderate Alzheimer's Disease with or without other etiologies of dementia
- Mini Mental Status Examination score of 10-26
Exclusion
- Contraindication as stated in the Canadian label for donepezil
- Subjects treated with medication for dementia within 30 days prior to baseline
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT00843115
Start Date
February 1 2007
End Date
April 1 2008
Last Update
March 13 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.